Becoña 2002.

Study characteristics
Methods	Study design: secondary analysis of RCT Country: Spain Data collection period: not stated Registry ID: not reported
Participants	Number of participants: N = 214; Number included in meta‐analysis: N = 200 Sample characteristics (at baseline): Age (mean): 37.3 years (SD 10.3); Sex (% male): 53% (106/200) Population category: general population; Specific population: people seeking treatment for smoking who do not use NRT, other drugs, or receive psychotherapy Nicotine dependence: FTND 5.4 (SD 2.4); Baseline cigarettes per day: 26.4 (SD 10.4); Motivation to quit: selected by motivation to quit
Interventions	Behavioural support for smoking cessation: multicomponent behavioural programme delivered in 6 weekly behavioural support sessions, including nicotine fading, withdrawal symptom avoidance and relapse prevention strategies Pharmacological support for smoking cessation: no pharmacological support Psychotherapeutic or psychoactive support for mental health or mood: did not receive mood management
Outcomes	Definition of cessation used: self‐reported point‐prevalence abstinence – immediately after programme (not smoking in previous 24 hours) and at the 3‐, 6‐ and 12‐month follow‐ups (not smoking previous 7 days; self‐reported continuous abstinence – at the 3‐, 6‐ and 12‐month follow‐ups (i.e. not smoking since initial quitting) Cessation definition used for outcome(s) in this analysis: point‐prevalence abstinence Measure of biovalidation: expired CO (< 9 ppm) Definition of people who continued smoking used: not stated Time point(s) at which follow‐up was conducted: immediately after programme (no smoking in previous 24 hours) and at 3‐, 6‐ and 12‐month follow‐ups (no smoking in previous 7 days) Outcome category: Anxiety Outcome measure(s): State Trait Anxiety Inventory (STAI)
Funding source	None specified
Author conflicts of interest	None specified
Notes	Outcome data source: Published data